What is Global Femoral Cannula Market?
The Global Femoral Cannula Market is a specialized sector within the broader medical device industry. The femoral cannula is a tube-like device that is inserted into the femoral vein or artery, primarily during cardiovascular surgeries, to facilitate the flow of blood or other fluids. This market encompasses the production, distribution, and application of these devices on a global scale. The market's value is determined by the demand for these devices in various healthcare settings, including hospitals, clinics, and surgical centers. The femoral cannula is a critical component in many surgical procedures, and its global market reflects the ongoing need for advanced, reliable, and efficient medical devices in today's healthcare landscape.
Unipolar, Bipolar in the Global Femoral Cannula Market:
The Global Femoral Cannula Market is divided into two main segments: unipolar and bipolar. Unipolar femoral cannulas are designed with a single lumen or channel, making them suitable for procedures that require only one type of fluid transfer. On the other hand, bipolar femoral cannulas feature two lumens, allowing for simultaneous inflow and outflow of fluids. This makes them ideal for more complex procedures. The choice between unipolar and bipolar femoral cannulas depends on the specific requirements of the surgical procedure. Both types have their unique advantages and are essential to the overall market.
Traditional extracorporeal circulation surgery, Extracorporeal membrane oxygenation (ECMO), Hemodialysis, Other in the Global Femoral Cannula Market:
The Global Femoral Cannula Market finds its application in various areas. In traditional extracorporeal circulation surgery, the femoral cannula is used to divert blood away from the heart, allowing surgeons to operate on a bloodless field. In Extracorporeal Membrane Oxygenation (ECMO), the cannula is used to oxygenate the blood outside the body, providing life support to patients with severe lung or heart conditions. Hemodialysis, a treatment for kidney failure, also utilizes femoral cannulas to remove waste products from the blood. Other applications include emergency medicine and intensive care, where femoral cannulas are used for rapid fluid replacement.
Global Femoral Cannula Market Outlook:
Looking at the market outlook, the Global Femoral Cannula Market was valued at a significant US$ 35 million in 2023. The market is expected to experience substantial growth, with projections estimating it to reach a value of US$ 52 million by 2030. This represents a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period from 2024 to 2030. This growth can be attributed to the increasing prevalence of cardiovascular diseases and the rising demand for advanced surgical procedures.
| Report Metric | Details |
| Report Name | Femoral Cannula Market |
| Accounted market size in 2023 | US$ 35 million |
| Forecasted market size in 2030 | US$ 52 million |
| CAGR | 5.7% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Changzhou KangXin Medical Instruments Co., Ltd., Chalice Medical Ltd., Xenios AG |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
